🟢 Immunic is trading 5.2% up today on stock-specific strength despite a weak biotech tape

Immunic is trading 5.2% up at $15.40 on stock-specific strength, notably outperforming a broader downturn in the biotechnology sector.

• There are no fresh company-specific headlines, earnings, or clinical trial readouts to explain the move, suggesting individual volatility.
• The gain comes as the SPDR S&P Biotech ETF (XBI) trades meaningfully lower, highlighting the stock's relative strength.
• In the absence of new disclosures, traders may be leaning on prior bullish sentiment or broader risk-on conditions.